Clinical trial

Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)

NCT00231309 · Emory University, Other · Completed

Key facts

NCT number NCT00231309
Title Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
Official title Pilot Study of Using Granulocyte Colony Stimulating Factor-Primed Bone Marrow in Histocompatible Sibling Allogeneic Bone Marrow Transplantation for Patients With Hematologic Malignancies and Non-Malignancies
Lead sponsor Emory University, Other
Status Completed
Study type Interventional
Conditions Hematologic Diseases, Hematologic Malignancies
Intervention type Drug
Interventions Granulocyte Colony Stimulating Factor
Enrollment 10
Start date Jul 1, 2003
Primary completion Nov 1, 2011
Completion Nov 1, 2011
First posted Oct 4, 2005
Last update posted Aug 22, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies